Tat by itself significantly reduced proBDNF in wild-type cultures versus control cultures at 6 h, with a strong trend towards reduction in both wild-type and CCR5-deficient cultures at 24 h (Fig. 7a (ii, v)).
← all excerpts
A central role for glial CCR5 in directing the neuropathological interactions of HIV-1 Tat and opiates.
1
—
—